HomePHAT • NASDAQ
Phathom Pharmaceuticals Inc
add
$6.69
0.00%
Pre-market:(1.20%)-0.080
$6.61
Closed: Mar 28, 8:52:26 AM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 29.66M | 4,249.56% |
Operating expense | 85.27M | 21.13% |
Net income | -74.45M | 6.43% |
Net profit margin | -250.98 | 97.85% |
Earnings per share | -1.05 | -31.25% |
EBITDA | -59.22M | 15.02% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 297.26M | -22.06% |
Total assets | 378.32M | -8.58% |
Total liabilities | 631.90M | 29.86% |
Total equity | -253.58M | — |
Shares outstanding | 69.64M | — |
Price to book | -1.81 | — |
Return on assets | -38.82% | — |
Return on capital | -46.91% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -74.45M | 6.43% |
Cash from operations | -63.46M | -44.89% |
Cash from investing | -5.00K | 98.95% |
Cash from financing | 26.05M | -87.71% |
Net change in cash | -37.42M | -122.31% |
Free cash flow | -43.94M | -121.18% |
Previous close
$6.69
Year range
$4.07 - $19.71
Market cap
465.87M USD
Avg Volume
1.23M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
427
